Clinical and pathophysiological implications of a bicuspid aortic valve

PWM Fedak, S Verma, TE David, RL Leask… - Circulation, 2002 - Am Heart Assoc
PWM Fedak, S Verma, TE David, RL Leask, RD Weisel, J Butany
Circulation, 2002Am Heart Assoc
You are contacted by a concerned 34-year-old airline pilot with a leaky bicuspid aortic valve
recently diagnosed by an echocardiogram that had been requested by his new employer as
part of a routine medical assessment. He claims that he is perfectly healthy but is at risk of
losing his job over his condition. He is concerned that his disease is hereditary and that his
children may also be at risk. The patient, his attorney, and his insurance company have
requested a statement from you as to the cause, possible complications, and treatment …
You are contacted by a concerned 34-year-old airline pilot with a leaky bicuspid aortic valve recently diagnosed by an echocardiogram that had been requested by his new employer as part of a routine medical assessment. He claims that he is perfectly healthy but is at risk of losing his job over his condition. He is concerned that his disease is hereditary and that his children may also be at risk. The patient, his attorney, and his insurance company have requested a statement from you as to the cause, possible complications, and treatment options associated with a congenital malformation of the aortic valve.
The bicuspid aortic valve (BAV) is the most common congenital cardiac malformation, occurring in 1% to 2% of the population. The majority of BAV patients develop complications requiring treatment. Physicians are often challenged when asked to provide evidence-based advice about BAV disease because the pathogenesis and pathophysiology of this disease are not well understood.
Am Heart Assoc